Indication
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes. Read more about Chronic lymphocytic leukemia
23 drugs 15 manufacturers
Drugs that treat it
Common Chronic lymphocytic leukemia therapies.
BREYANZI CD4 COMPONENT (2OF 2) (lisocabtagene maraleucel, CD4 component, 2 of 2)
BREYANZI CD4 COMPONENT (lisocabtagene maraleucel, CD4 component, 2 of 2)
BREYANZI CD8 COMPONENT (lisocabtagene maraleucel, CD8 component, 1 of 2)
ARZERRA (ofatumumab)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes.
Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues.
Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painless lymphadenopathy, hepatosplenomegaly, and increased susceptibility to infections secondary to impaired immune function.
- nih.gov
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painles...
- nih.gov
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painless lymphadenopathy, hepatosplenomegaly, and increased susceptibility to infections secondary to impaired immune...
- nih.gov
Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues
Personalize your experience
Follow Chronic lymphocytic leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.